Department of Cardiology, University Hospital, Heart Center, Rostock, Germany.
Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1224-31. doi: 10.1002/ccd.24538. Epub 2013 Feb 26.
The purpose of this study was to compare outcomes using standard clipping (SC) (one to two clips) or multiple clipping (MC) (more than two clips).
MitraClip implantation using MC has been proposed to treat severe mitral regurgitation (MR) in high-risk patients.
A tailored strategy was used implanting as many clips as required to eliminate MR. A total of 85 consecutive patients [78 ± 6 years, 48 men (56.5%) ] with MR (grade 3+ or 4+) were included. EuroSCORE was 24 ± 12 (2.5-56.3) and STS-score 12 ± 7 (1.2-31.2). SC was used in 61 (71.8%) and MC in 24 (28.2%) patients. Patients in MC group had larger mitral valve (MV) annuli (P = 0.025), MV orifice areas (MVOA) (P = 0.01), and MR degree (P = 0.005). Successful clip placement was achieved in 82 patients (96.5%). At discharge, no patient had grade 4+ MR. MR 3+ presented in 4 patients (7.0%) in the SC group and in 1 (4.5%) in the MC group (P = 0.72). There were 3 (3.5%) in-hospital deaths. Follow up (211 ± 173 days, range 4-652) echocardiography confirmed similar MVOA (P = 0.83) and MV gradients (P = 0.54) in the both groups. At linear regression there was no independent correlation between clips number and postoperative MVOA/gradient. One-year survival was 71.1% without difference between groups (P = 0.74).
Although the hemodynamic and anatomical basis of MR may differ, every procedure should aim at eliminating MR. In some patients this goal can be achieved using MC with minimized risk of MV stenosis if preoperative anatomy/mechanism of MV regurgitation are adequately assessed.
本研究旨在比较标准夹闭(SC)(1-2 个夹)和多次夹闭(MC)(>2 个夹)的治疗效果。
MC 被提议用于治疗高危患者的严重二尖瓣反流(MR)。
采用量身定制的策略,根据需要植入尽可能多的夹子以消除 MR。共纳入 85 例连续患者[78±6 岁,48 名男性(56.5%)],MR 分级为 3+或 4+。EuroSCORE 为 24±12(2.5-56.3),STS 评分为 12±7(1.2-31.2)。61 例患者采用 SC,24 例患者采用 MC。MC 组患者的二尖瓣瓣环(MV)较大(P=0.025),MV 口面积(MVOA)较大(P=0.01),MR 程度更严重(P=0.005)。82 例患者(96.5%)成功植入夹子。出院时,无患者出现 4+MR。SC 组有 4 例(7.0%)和 MC 组有 1 例(4.5%)患者出现 3+MR(P=0.72)。住院期间有 3 例(3.5%)死亡。在 211±173 天(4-652 天)的随访中,两组的 MVOA(P=0.83)和 MV 梯度(P=0.54)相似。线性回归显示,夹子数量与术后 MVOA/梯度无独立相关性。1 年生存率为 71.1%,两组无差异(P=0.74)。
尽管 MR 的血流动力学和解剖基础可能不同,但每个手术都应旨在消除 MR。如果术前 MV 反流的解剖/机制得到充分评估,则在某些患者中,通过 MC 可以以最小的 MV 狭窄风险达到这一目标。